IHC - Multiple Myeloma Oncogene 1 (MUM1) Test Cost & Procedure

It is possible to employ MUM1 as a marker for lymphohematopoietic neoplasms developing from activated T cells and late plasma cell-driven stages of B cell development because of the multiple myeloma oncogene's expression in these cells.

MUM1 is expressed in extraosseous plasmacytomas and plasma cell myeloma. Melanomas have been found to express MUM-1 among non-hematolymphoid neoplasms.

What is this test?

MUM1 is a gene that is used for proteins. Its name, Multiple Myeloma Oncogene-1, or MUM-1, is how it is expressed. Melanoma is one condition that MUM1 affects many people. The MUM1 gene's coding demonstrates that it is one of the factors contributing to DNA damage and chromosomal abnormalities. Immunohistochemistry and tissue microarrays are used to perform the MUM 1 protein test.

The process is known as immunohistochemical staining (IHC). Consequently, the Mum1 gene encodes the 50 kDa MUM 1 protein. Antigen-stimulated B cells that can develop into plasma cells are the source of MUM 1 expression.

Preparation for this Test

A patient must follow the doctors' instructions, nevertheless. He might be instructed to skip his existing medications or to fast for the duration of the test.

Mum1 Protein Test Applications

Determine if there are any malignancy-related symptoms. It facilitates additional research into hematolymphoid neoplasm. The test enables medical professionals to recognise melanomas and begin appropriate treatment.

The procedure of this test

• The test's methodology is known as immunohistochemistry (IHC).
• It resembles a staining procedure. By using the idea that antibodies bind to antigens in biological tissues, it seeks to select the MUM 1 protein in cells of a tissue segment.
• Under a light microscope, the antigen-antibody response can be seen.
• The techniques are employed to find the particular protein in the sample. M